<DOC>
	<DOCNO>NCT00503516</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy megestrol acetate gain body weight patient primary mixed Dementia weight loss .</brief_summary>
	<brief_title>Study Evaluate Effect Megestrol Acetate Weight Loss Dementia Patients</brief_title>
	<detailed_description>In geriatric patient dementia prove weight loss independently institutionalize not.There previous study indicate effect megestrol acetate weight gain patient cachexia-anorexia related neoplasia . It seem mechanism development could patient patient dementia . It describe important role group cytokine ( Il-6 , leptin , neuropeptide Y , TNFalfa ) development nutritional alteration . Some previous pilot study indicate megestrol acetate effect geriatric dementia patient weight loss least 5 % last 6 month .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Patients diagnose primary mixed dementia ( CIE 10criteria ) Weihgt loss &gt; 5 % habitual weight last 6 month proteiccaloric malnutrition ( MNA &lt; 17 ) Outpatients Patients accept participation study Vascular pure Dementia secondary dementia ( vascular dementia , Parkinson disease , etc ) Dementia terminal phase : category FAST 7c Reisber scale Concomitant treatment steroid , androgen drug progestagens Weight loss secondary neoplasia</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>weight loss , appetite , dementia , megestrol acetate</keyword>
</DOC>